REPORT ID 4196

EMEA (Europe, Middle East and Africa) Fibrinogen Concentrates Market Report 2017

Publish Date
15-Dec-17
Pages
116
Format
Electronic (PDF)

In this report, the EMEA Fibrinogen Concentrates market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Fibrinogen Concentrates for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Fibrinogen Concentrates market competition by top manufacturers/players, with Fibrinogen Concentrates sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
    CSL Behring
    Baxter
    Johnson & Johnson (Ethicon)
    LFB Group
    ProFibrix BV (The Medicines Company)
    Shanghai RAAS
    Jiangxi Boya Bio-Pharmaceutical
    Hualan Biological Engineering
    Harbin Pacific Biopharmaceutical
    Greencross
    Shanghai XinXing Medical

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Human Fibrinogen Concentrate
    Animal Fibrinogen Concentrate

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Congenital Fibrinogen Deficiency
    Surgical Procedures

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Fibrinogen Concentrates Market Report 2017
1 Fibrinogen Concentrates Overview
    1.1 Product Overview and Scope of Fibrinogen Concentrates
    1.2 Classification of Fibrinogen Concentrates
        1.2.1 EMEA Fibrinogen Concentrates Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Fibrinogen Concentrates Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Human Fibrinogen Concentrate
        1.2.4 Animal Fibrinogen Concentrate
    1.3 EMEA Fibrinogen Concentrates Market by Application/End Users
        1.3.1 EMEA Fibrinogen Concentrates Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Congenital Fibrinogen Deficiency
        1.3.3 Surgical Procedures
    1.4 EMEA Fibrinogen Concentrates Market by Region
        1.4.1 EMEA Fibrinogen Concentrates Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Fibrinogen Concentrates (2012-2022)
        1.5.1 EMEA Fibrinogen Concentrates Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Fibrinogen Concentrates Revenue and Growth Rate (2012-2022)

2 EMEA Fibrinogen Concentrates Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Fibrinogen Concentrates Market Competition by Players/Manufacturers
        2.1.1 EMEA Fibrinogen Concentrates Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Fibrinogen Concentrates Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Fibrinogen Concentrates Sale Price by Players (2012-2017)
    2.2 EMEA Fibrinogen Concentrates (Volume and Value) by Type/Product Category
        2.2.1 EMEA Fibrinogen Concentrates Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Fibrinogen Concentrates Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Fibrinogen Concentrates Sale Price by Type (2012-2017)
    2.3 EMEA Fibrinogen Concentrates (Volume) by Application
    2.4 EMEA Fibrinogen Concentrates (Volume and Value) by Region
        2.4.1 EMEA Fibrinogen Concentrates Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Fibrinogen Concentrates Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Fibrinogen Concentrates Sales Price by Region (2012-2017)

3 Europe Fibrinogen Concentrates (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Fibrinogen Concentrates Sales and Value (2012-2017)
        3.1.1 Europe Fibrinogen Concentrates Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Fibrinogen Concentrates Revenue and Growth Rate (2012-2017)
    3.2 Europe Fibrinogen Concentrates Sales and Market Share by Type
    3.3 Europe Fibrinogen Concentrates Sales and Market Share by Application
    3.4 Europe Fibrinogen Concentrates Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Fibrinogen Concentrates Sales Volume by Countries (2012-2017)
        3.4.2 Europe Fibrinogen Concentrates Revenue by Countries (2012-2017)
        3.4.3 Germany Fibrinogen Concentrates Sales and Growth Rate (2012-2017)
        3.4.4 France Fibrinogen Concentrates Sales and Growth Rate (2012-2017)
        3.4.5 UK Fibrinogen Concentrates Sales and Growth Rate (2012-2017)
        3.4.6 Russia Fibrinogen Concentrates Sales and Growth Rate (2012-2017)
        3.4.7 Italy Fibrinogen Concentrates Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Fibrinogen Concentrates Sales and Growth Rate (2012-2017)

4 Middle East Fibrinogen Concentrates (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Fibrinogen Concentrates Sales and Value (2012-2017)
        4.1.1 Middle East Fibrinogen Concentrates Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Fibrinogen Concentrates Revenue and Growth Rate (2012-2017)
    4.2 Middle East Fibrinogen Concentrates Sales and Market Share by Type
    4.3 Middle East Fibrinogen Concentrates Sales and Market Share by Application
    4.4 Middle East Fibrinogen Concentrates Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Fibrinogen Concentrates Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Fibrinogen Concentrates Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Fibrinogen Concentrates Sales and Growth Rate (2012-2017)
        4.4.4 Israel Fibrinogen Concentrates Sales and Growth Rate (2012-2017)
        4.4.5 UAE Fibrinogen Concentrates Sales and Growth Rate (2012-2017)
        4.4.6 Iran Fibrinogen Concentrates Sales and Growth Rate (2012-2017)

5 Africa Fibrinogen Concentrates (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Fibrinogen Concentrates Sales and Value (2012-2017)
        5.1.1 Africa Fibrinogen Concentrates Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Fibrinogen Concentrates Revenue and Growth Rate (2012-2017)
    5.2 Africa Fibrinogen Concentrates Sales and Market Share by Type
    5.3 Africa Fibrinogen Concentrates Sales and Market Share by Application
    5.4 Africa Fibrinogen Concentrates Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Fibrinogen Concentrates Sales Volume by Countries (2012-2017)
        5.4.2 Africa Fibrinogen Concentrates Revenue by Countries (2012-2017)
        5.4.3 South Africa Fibrinogen Concentrates Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Fibrinogen Concentrates Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Fibrinogen Concentrates Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Fibrinogen Concentrates Sales and Growth Rate (2012-2017)

6 EMEA Fibrinogen Concentrates Manufacturers/Players Profiles and Sales Data
    6.1 CSL Behring
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Fibrinogen Concentrates Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 CSL Behring Fibrinogen Concentrates Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Baxter
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Fibrinogen Concentrates Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Baxter Fibrinogen Concentrates Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Johnson & Johnson (Ethicon)
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Fibrinogen Concentrates Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Johnson & Johnson (Ethicon) Fibrinogen Concentrates Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 LFB Group
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Fibrinogen Concentrates Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 LFB Group Fibrinogen Concentrates Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 ProFibrix BV (The Medicines Company)
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Fibrinogen Concentrates Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 ProFibrix BV (The Medicines Company) Fibrinogen Concentrates Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Shanghai RAAS
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Fibrinogen Concentrates Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Shanghai RAAS Fibrinogen Concentrates Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Jiangxi Boya Bio-Pharmaceutical
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Fibrinogen Concentrates Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Jiangxi Boya Bio-Pharmaceutical Fibrinogen Concentrates Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Hualan Biological Engineering
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Fibrinogen Concentrates Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Hualan Biological Engineering Fibrinogen Concentrates Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Harbin Pacific Biopharmaceutical
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Fibrinogen Concentrates Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Harbin Pacific Biopharmaceutical Fibrinogen Concentrates Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Greencross
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Fibrinogen Concentrates Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Greencross Fibrinogen Concentrates Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Shanghai XinXing Medical

7 Fibrinogen Concentrates Manufacturing Cost Analysis
    7.1 Fibrinogen Concentrates Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Fibrinogen Concentrates

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Fibrinogen Concentrates Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Fibrinogen Concentrates Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Fibrinogen Concentrates Market Forecast (2017-2022)
    11.1 EMEA Fibrinogen Concentrates Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Fibrinogen Concentrates Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Fibrinogen Concentrates Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Fibrinogen Concentrates Price and Trend Forecast (2017-2022)
    11.2 EMEA Fibrinogen Concentrates Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Fibrinogen Concentrates Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Fibrinogen Concentrates Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Fibrinogen Concentrates Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Fibrinogen Concentrates Sales Forecast by Type (2017-2022)
    11.7 EMEA Fibrinogen Concentrates Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer